Recordati Industria Chimica e Farmaceutica S.p.A.

General ticker "RCDTF" information:

  • Sector: Health Care
  • Industry: Drug Manufacturers - General
  • Capitalization: $12.9B (TTM average)

Recordati Industria Chimica e Farmaceutica S.p.A. follows the US Stock Market performance with the rate: 8.5%.

Estimated limits based on current volatility of 0.0%: low 55.88$, high 55.88$

Factors to consider:

  • Earnings expected soon, date: nan
  • Company pays dividends (semi-annually): last record date 2025-11-25, amount 0.73$ (Y2.61%)

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [57.35$, 78.60$]
  • 2026-12-31 to 2027-12-31 estimated range: [64.71$, 87.13$]

Financial Metrics affecting the RCDTF estimates:

  • Negative: with PPE of 18.6 at the end of fiscal year the price was high
  • Positive: Operating profit margin, % of 27.49 > 18.52
  • Positive: 0.07 < Operating cash flow per share per price, % of 5.19
  • Positive: Industry operating profit margin (median), % of 26.76 > 9.67
  • Positive: 19.49 < Shareholder equity ratio, % of 36.55 <= 42.60
  • Positive: Industry earnings per price (median), % of 6.05 > 4.54
  • Positive: Inventory ratio change, % of -0.69 <= 0
  • Positive: 5.46 < Industry operating cash flow per share per price (median), % of 6.51
  • Positive: Return on assets ratio (scaled to [-100,100]) of 7.79 > 6.12

Similar symbols

Short-term RCDTF quotes

Long-term RCDTF plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue €2,082.33MM €2,341.56MM €2,618.38MM
Operating Expenses €1,524.32MM €1,702.70MM €1,898.64MM
Operating Income €558.01MM €638.86MM €719.74MM
Non-Operating Income €-66.97MM €-91.67MM €-138.47MM
Interest Expense €74.86MM €81.55MM €99.29MM
R&D Expense €255.75MM €286.03MM €340.95MM
Income(Loss) €491.04MM €547.18MM €581.27MM
Taxes €101.82MM €130.68MM €137.65MM
Profit(Loss)* €389.21MM €416.51MM €443.62MM
Stockholders Equity €1,686.39MM €1,876.81MM €1,919.77MM
Inventory €404.83MM €506.45MM €539.80MM
Assets €4,208.13MM €5,134.45MM €5,252.27MM
Operating Cash Flow €485.32MM €569.92MM €596.90MM
Capital expenditure €383.26MM €851.16MM €85.12MM
Investing Cash Flow €-379.62MM €-844.94MM €-80.84MM
Financing Cash Flow €-168.91MM €372.11MM €-407.02MM
Earnings Per Share** €1.86 €2.02 €2.15

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.